checkAd
    Startseite > Aktien > COMPASS Pathways > Nachrichten
    COMPASS Pathways Aktie
    8,1000
     
    USD
    -1,82 %
    -0,1500 USD
    Letzter Kurs 02:00:00 Nasdaq
    8,0700
     
    USD
    800 STK
    Geldkurs 24.04.24
    8,1100
     
    USD
    2.500 STK
    Briefkurs 24.04.24
    ISIN: US20451W1018 · WKN: A2QCDR · SYM: CMPS · Großbritannien

    Neueste Nachrichten

    Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
    01.04.24 · globenewswire · COMPASS Pathways
    Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
    28.03.24 · globenewswire · COMPASS Pathways
    Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 
    29.02.24 · globenewswire · COMPASS Pathways
    Compass Pathways to participate in upcoming TD Cowen investor conference
    26.02.24 · globenewswire · COMPASS Pathways
    Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
    22.02.24 · globenewswire · COMPASS Pathways
    Compass Pathways to participate in upcoming Oppenheimer investor conference
    31.01.24 · globenewswire · COMPASS Pathways
    Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
    16.01.24 · globenewswire · COMPASS Pathways
    Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
    05.01.24 · globenewswire · COMPASS Pathways
    Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder
    19.12.23 · globenewswire · COMPASS Pathways
    Compass Pathways to participate in upcoming Evercore investor conference
    24.11.23 · globenewswire · COMPASS Pathways
    Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center
    15.11.23 · globenewswire · COMPASS Pathways
    COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights
    02.11.23 · globenewswire · COMPASS Pathways